These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889 [TBL] [Abstract][Full Text] [Related]
3. Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience. Moruf A; Spyropoulos AC; Schardt TQ; Gibson E; Manco-Johnson MJ; Wang M; Goldenberg NA Thromb Res; 2012 Oct; 130(4):612-5. PubMed ID: 22749329 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement. Mathew JG; Spyropoulos AC; Yusuf A; Vincent J; Eikelboom J; Shestakovska O; Fremes S; Noora J; Guo L; Peterson M; Pai M; Whitlock R Thromb Haemost; 2014 Dec; 112(6):1120-8. PubMed ID: 25183209 [TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
6. Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study. Eljilany I; Elarref M; Shallik N; Elzouki AN; Mohammed A; Shoman B; Ibrahim S; Carr C; Al-Badriyeh D; Cavallari LH; Elewa H Curr Probl Cardiol; 2021 Jun; 46(6):100816. PubMed ID: 33721568 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists. Ríos SJ; Rivera-Caravaca JM; Aroca-Valverde C; Reguilón-Gallego L; Castillo-Rodríguez M; Esteve-Pastor MA; Vicente V; Marín F; Roldán V QJM; 2019 Mar; 112(3):183-188. PubMed ID: 30380132 [TBL] [Abstract][Full Text] [Related]
8. Periprocedural bridging anticoagulation: current perspectives. Palaniswamy C; Selvaraj DR Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672 [TBL] [Abstract][Full Text] [Related]
9. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197 [TBL] [Abstract][Full Text] [Related]
11. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL; N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867 [TBL] [Abstract][Full Text] [Related]
12. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063 [TBL] [Abstract][Full Text] [Related]
13. Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings. Nikolakopoulos I; Spyropoulos AC Semin Thromb Hemost; 2020 Feb; 46(1):26-31. PubMed ID: 31830765 [TBL] [Abstract][Full Text] [Related]
14. [Antithrombotic therapy and digestive endoscopy]. Cyrany J; Malý R; Rejchrt S; Tachecí I Vnitr Lek; 2022; 68(8):538-542. PubMed ID: 36575073 [TBL] [Abstract][Full Text] [Related]
15. Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Attaya H; Shah ND; Wysokinski WE; Van Houten HK; Heit JA; McBane RD Int J Cardiol; 2013 Oct; 168(6):5311-5. PubMed ID: 23998551 [TBL] [Abstract][Full Text] [Related]
16. Impact of educational intervention on management of periprocedural anticoagulation. Awker AL; Bell MA; McGraw M; Klein MA Am J Health Syst Pharm; 2017 Dec; 74(23 Supplement 4):S95-S101. PubMed ID: 29167146 [TBL] [Abstract][Full Text] [Related]
17. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746 [TBL] [Abstract][Full Text] [Related]
18. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S; Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892 [TBL] [Abstract][Full Text] [Related]
19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]